Skip to main content


  • Sunday, Aug 24th
    10:30 AM - 10:45 AM ET
    1E-01 - Dose-Dependent Risk of Psychosis in Patients with Attention-Deficit/Hyperactivity Disorder Treated with Prescription Amphetamine
    Presenting Author: Loreen Straub – Brigham and Women’s Hospital and Harvard Medical School
    Co-Author: Jun Liu – Brigham and Women's Hospital/Harvard Medical School, Boston, MA
    Co-Author: Joseph Skinner – Brigham and Women's Hospital/Harvard Medical School, Boston, MA
    Co-Author: Lauren Moran – McLean Hospital
    Safety Outcomes / Neurological/Mental Health
  • Sunday, Aug 24th
    11:15 AM - 11:30 AM ET
    1E-04 - Comparative risk of sedative-related use disorders following benzodiazepine treatment versus alternative treatments in adolescents and young adults
    Presenting Author: Greta Bushnell – Rutgers University
    Co-Author: Katherine Keyes – Columbia University
    Co-Author: Sean McCabe – University of Michigan
    Co-Author: Magdalena Cerda – New York University
    Co-Author: Tobias Gerhard, PhD – Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research
    Co-Author: Deborah Hasin – Columbia University
    Co-Author: Zhuoyue Gou – Rutgers University
    Co-Author: Mark Olfson, MD, MPH – Columbia University
    Safety Outcomes / Neurological/Mental Health
  • Sunday, Aug 24th
    3:30 PM - 3:45 PM ET
    2B-01 - Risk of Neurodevelopmental Disorders with Fetal Azithromycin and β-lactam Exposure
    Presenting Author: Marianne N. Otoo, MPharm, BPharm – University of Rhode Island
    Co-Author: Thomas Lavoie, PharmD – University of Rhode Island
    Co-Author: Todd Brothers, PharmD, BCCCP, BCPS – University of Rhode Island
    Co-Author: Kristina E. Ward, PharmD, BCPS – University of Rhode Island
    Co-Author: Nicole Asal, PharmD, BCPS – University of Rhode Island
    Co-Author: Xuerong Wen, PhD, MS, MPH – University of Rhode Island
    Safety Outcomes / Neurological/Mental Health
  • Sunday, Aug 24th
    4:45 PM - 5:00 PM ET
    2B-06 - Use of fluoroquinolones and the risk of seizures: a population-based cohort study
    Presenting Author: Paraskevi Tassopoulou – Charité - Universitätsmedizin Berlin
    Co-Author: Annika Vivirito – InGef Institute
    Co-Author: Philip Heinemann – InGef Institute
    Co-Author: Dirk Enders – InGef Institute
    Co-Author: Antonios Douros – Universitätsmedizin Berlin
    Safety Outcomes / Neurological/Mental Health
  • Monday, Aug 25th
    8:45 AM - 9:00 AM ET
    3F-03 - Tiotropium Initiation and Dementia Risk in Older Adults with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
    Presenting Author: Che-Yuan Wu – University of Toronto, Toronto, Ontario, Canada
    Co-Author: Tetyana Kendzerska – University of Ottawa, Ottawa, Ontario, Canada
    Co-Author: Christa Wang – ICES, Toronto, Ontario, Canada
    Co-Author: Lisa Y. Xiong – University of Toronto, Toronto, Ontario, Canada
    Co-Author: Jodi D. Edwards – University of Ottawa, Ottawa, Ontario, Canada
    Co-Author: Peter P. Liu – University of Ottawa, Ottawa, Ontario, Canada
    Co-Author: Refik Saskin – ICES, Toronto, Ontario, Canada
    Co-Author: Walter Swardfager – University of Toronto, Toronto, Ontario, Canada
    Safety Outcomes / Neurological/Mental Health
  • Monday, Aug 25th
    5:30 PM - 5:45 PM ET
    4B-06 - The Risk of Dementia with hormone-modulating Breast Cancer Therapies Used in Older Women: A Target Trial Emulation Study
    Presenting Author: Jieni Li, PhD, MPH – University of Houston College of Pharmacy
    Co-Author: Soumya Chikermane, PhD – University of Houston College of Pharmacy
    Co-Author: Xi Lu, PhD – University of Houston College of Pharmacy
    Co-Author: Rajender Aparasu, PhD – University of Houston College of Pharmacy
    Safety Outcomes / Neurological/Mental Health
  • Tuesday, Aug 26th
    9:00 AM - 9:15 AM ET
    5E-03 - GLP-1 Receptor Agonists and the Risk of Suicidality Among Patients With Type 2 Diabetes
    Presenting Author: Samantha Shapiro, MSc – McGill University
    Co-Author: Hui Yin – Lady Davis Institute for Medical Research
    Co-Author: Oriana Hoi Yun Yu, MD, MSc – McGill University
    Co-Author: Soham Rej – McGill University
    Co-Author: Samy Suissa – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada; Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada; Department of Medicine, McGill University, Montreal, Canada
    Co-Author: Laurent Azoulay, PhD – Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada
    Safety Outcomes / Neurological/Mental Health
  • Tuesday, Aug 26th
    9:15 AM - 9:30 AM ET
    5E-04 - Comparative safety of glucagon-like peptide 1 receptor agonists (GLP-1-RAs) in chronic weight management patients without diabetes: a real-world data study
    Presenting Author: Sarah R. Hoffman – Carelon Research
    Co-Author: Stephan Lanes – Carelon Research
    Co-Author: Tracey Quimbo – Carelon Research
    Co-Author: Anahit Papazian – Carelon Research
    Co-Author: Jeff White – CarelonRx
    Co-Author: Vicki Fisher – CarelonRx
    Co-Author: Mark Cziraky – Carelon Research
    Co-Author: Matthew Crowley – Duke University Medical Center
    Co-Author: Vincent Willey – Carelon Research
    Safety Outcomes / Neurological/Mental Health
  • Tuesday, Aug 26th
    1:45 PM - 2:00 PM ET
    6G-02 - Levetiracetam Use and Dementia Risk in Patients with Post-Stroke Seizures: A Population-Based Study Using a Target Trial Emulation Framework
    Presenting Author: Hsin-Yi Huang, PhD, BCCCP – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA
    Co-Author: Xiaojuan Li, PhD, MSPH – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA
    Co-Author: Chi-Chuan Wang, PhD – National Taiwan University
    Safety Outcomes / Neurological/Mental Health